journal article·2021-01Open access

uPAR targeted phototheranostic metal-organic framework nanoprobes for MR/NIR-II imaging-guided therapy and surgical resection of glioblastoma

Zhike Li, Chenyuan Wang, Junrong Chen, Xiang Lian, Chuxiao Xiong, Rui Tian, Liefeng Hu, Xiaoxing Xiong, Jian Tian

Materials & Design· Volume 198

Abstract

Glioblastoma (GBM) is the most malignant brain tumor. Owing to its highly infiltrative nature and restrictive blood-brain tumor barrier (BBTB), the current treatment strategies, including surgery and the following chemoradiotherapy, offer very low efficacy. Therefore, it is highly desirable to develop novel multifunctional theranostic agents for visualized diagnosis and treatment of GBM. In this work, a phototheranostic nanoprobe ([email protected]), constructed of Fe-based metal-organic framework (MOF) nanoparticles loaded with a small-molecule near-infrared II (NIR-II) fluorophore (CH4T), is rationally designed and modified with tumor-targeting AE105 peptide for efficiently targeting the over-expressed urokinase Plasminogen Activator Receptor (uPAR) on GBM. The nanoplatform combines advantages of high penetration depth of magnetic resonance (MR) imaging with high detection sensitivity and spatiotemporal resolution of NIR-II fluorescence imaging, enabling it to diagnose and delineate GBM accurately. Besides, in vivo studies reveal that [email protected] can realize MR/NIR-II imaging-guided photothermal therapy (PTT), achieving successful ablation of U87MG tumors. More importantly, the nanoprobes can efficiently transport across the BBTB facilitated by active tumor-targeting and enrich in the orthotopic GBM tumors, being capable of guiding the surgical resection of GBM via real-time intraoperative NIR-II imaging. Our work provides new insights into developing theranostic nanoplatforms for efficient diagnosis and treatment of GBM.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. The definition of primary and secondary glioblastoma10.1158/1078-0432.CCR-12-3002 ↗
2. Estimating progression-free survival in patients with glioblastoma using routinely collected data10.1007/s11060-017-2619-1 ↗
3. Multifunctional nanoparticles for brain tumor imaging and therapy10.1016/j.addr.2013.09.006 ↗
4. Through scalp and skull NIR-II photothermal therapy of deep orthotopic brain tumors with precise photoacoustic imaging guidance10.1002/adma.201802591 ↗
5. Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing blood-brain barrier10.1016/j.biomaterials.2019.04.026 ↗
6. Transport of drugs across the blood-brain barrier by nanoparticles10.1016/j.jconrel.2011.08.017 ↗
7. Tumour stem cells and drug resistance10.1038/nrc1590 ↗
8. Chemotherapy resistance of glioblastoma stem cells10.1038/sj.cdd.4401872 ↗
9. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma10.1038/nrc2818 ↗
10. Brain shift during bur hole-based procedures using interventional MRI10.3171/2014.3.JNS121312 ↗
11. Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier10.1002/smll.201301673 ↗
12. Preoperative detection and intraoperative visualization of brain tumors for more precise surgery: a new dual-modality MRI and NIR nanoprobe10.1002/smll.201500997 ↗
13. Near-infrared fluorescence imaging in the largely unexplored window of 900-1,000 nm10.7150/thno.26539 ↗
14. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows10.1038/s41551-019-0494-0 ↗
15. A small-molecule dye for NIR-II imaging10.1038/nmat4476 ↗
16. Recent advances in the development of NIR-II organic emitters for biomedicine10.1016/j.ccr.2020.213318 ↗
17. A novel αvβ3 integrin-targeted NIR-II nanoprobe for multimodal imaging-guided photothermal therapy of tumors in vivo10.1039/C9NR10720G ↗
18. Stable, wavelength-tunable fluorescent dyes in the NIR-II region for in vivo high-contrast bioimaging and multiplexed biosensing10.1002/anie.201904182 ↗
19. Molecular targeted NIR-II probe for image-guided brain tumor surgery10.1021/acs.bioconjchem.8b00669 ↗
20. A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging10.1038/ncomms15269 ↗
21. Mn-loaded apolactoferrin dots for in vivo MRI and NIR-II cancer imaging10.1039/C9TC01929D ↗
22. Melanin-dot-mediated delivery of metallacycle for NIR-II/photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy10.1073/pnas.1908761116 ↗
23. All-in-one phototheranostics: single laser triggers NIR-II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy10.1002/adfm.201901480 ↗
24. Near-infrared II dye-protein complex for biomedical imaging and imaging-guided photothermal therapy10.1002/adhm.201800589 ↗
25. Polypeptide-conjugated second near-infrared organic fluorophore for image-guided photothermal therapy10.1021/acsnano.9b00452 ↗
26. Novel ultrasmall multifunctional nanodots for dual-modal MR/NIR-II imaging-guided photothermal therapy10.1016/j.biomaterials.2020.120219 ↗
27. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
28. Nanostructural control enables optimized photoacoustic-fluorescence-magnetic resonance multimodal imaging and photothermal therapy of brain tumor10.1002/adfm.201907077 ↗
29. Phototheranostics: active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles10.1021/acsnano.8b06556 ↗
30. Nanoparticles of metal-organic frameworks: on the road to in vivo efficacy in biomedicine10.1002/adma.201707365 ↗
31. Multistimuli responsive core-shell nanoplatform constructed from Fe3O4@MOF equipped with pillar[6]arene nanovalves10.1002/smll.201704440 ↗
32. A Mn(III)-sealed metal-organic framework nanosystem for redox-unlocked tumor theranostics10.1021/acsnano.9b00300 ↗
33. Nanostructured metal-organic frameworks and their bio-related applications10.1016/j.ccr.2015.08.008 ↗
34. Nanoscale metal-organic frameworks for therapeutic, imaging, and sensing applications10.1002/adma.201707634 ↗
35. Engineering phototheranostic nanoscale metal-organic frameworks for multimodal imaging-guided cancer therapy10.1021/acsami.6b11579 ↗
36. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
37. Multifunctional iron-based metal-organic framework as biodegradable nanozyme for microwave enhancing dynamic therapy10.1016/j.biomaterials.2019.119223 ↗
38. Controllable synthesis of a smart multifunctional nanoscale metal-organic framework for magnetic resonance/optical imaging and targeted drug delivery10.1021/acsami.6b14795 ↗
39. A multifunctional metal-organic framework based tumor targeting drug delivery system for cancer therapy10.1039/C5NR04045K ↗
40. Core-shell upconversion nanoparticle@metal-organic framework nanoprobes for luminescent/magnetic dual-mode targeted imaging10.1002/adma.201501779 ↗
41. ZD2-engineered gold nanostar@metal-organic framework nanoprobes for T1-weighted magnetic resonance imaging and photothermal therapy specifically toward triple-negative breast cancer10.1002/adhm.201801144 ↗
42. Progress and perspectives on targeting nanoparticles for brain drug delivery10.1016/j.apsb.2016.05.013 ↗
43. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles10.1016/j.biomaterials.2014.10.007 ↗
44. Peptide-based optical uPAR imaging for surgery: in vivo testing of ICG-Glu-Glu-AE10510.1371/journal.pone.0147428 ↗
45. Urokinase-type plasminogen activator receptor as a potential PET biomarker in glioblastoma10.2967/jnumed.115.161703 ↗
46. Safety, dosimetry, and tumor detection ability of Ga-68-NOTA-AE105: first-in-human study of a novel radioligand for uPAR PET imaging10.2967/jnumed.116.178970 ↗
47. First-in-human uPAR PET: imaging of cancer aggressiveness10.7150/thno.12956 ↗
48. Controlled nucleation and controlled growth for size predicable synthesis of nanoscale metal-organic frameworks (MOFs): a general and scalable approach10.1002/anie.201803766 ↗
49. A near infrared light triggered hydrogenated black TiO2 for cancer photothermal therapy10.1002/adhm.201500273 ↗
50. Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas10.1038/srep07958 ↗
51. Perfluorooctyl bromide & indocyanine green co-loaded nanoliposomes for enhanced multimodal imaging-guided phototherapy10.1016/j.biomaterials.2018.02.041 ↗
52. Light/pH-triggered biomimetic red blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal therapy10.1021/acsami.9b00897 ↗
53. Small-sized MOF-constructed multifunctional diagnosis and therapy platform for tumor10.1021/acsbiomaterials.9b00813 ↗
54. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using Ga-68-IRDye800CW-BBN10.7150/thno.25599 ↗
55. NIRF nanoprobes for cancer molecular imaging: approaching clinic10.1016/j.molmed.2020.02.003 ↗